ClinicalTrials.gg
RecruitingNCT05395715Updated Feb 9, 2026

Conditioning Electrical Stimulation to Improve Outcomes in Cubital Tunnel Syndrome

An interventional study of Electrical stimulation in Cubital Tunnel Syndrome and Electrical Stimulation, sponsored by University of Alberta. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-09.

Sponsored by University of Alberta · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2022; still recruiting 4 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 79 Years
Sex
All
01

Study summary

Cubital tunnel syndrome is the second most common compression neuropathy. In severe cases, functional recovery, even with surgery, is often poor. Therefore, alternative adjunct treatments capable of increasing the speed of nerve regeneration are much needed.

Read the detailed description

The effect of brief conditioning electrical stimulation on nerve regeneration has been showed to be efficacy in animal studies. In this double-blind, randomized, controlled study, the investigators will compare the physiological and functional improvements post surgery compared with the controls who received surgery alone. Because electrical stimulation is reasonably well-tolerated and the treatment only takes an hour, it is a potentially feasible clinical tool for patients with severe nerve injury.

02

Conditions studied

  • Cubital Tunnel Syndrome
  • Electrical Stimulation

Keywords

  • Cubital tunnel syndrome
  • Nerve regeneration
  • Electrical stimulation
  • Functional outcomes
  • Randomized control trial
  • Surgery
  • Peripheral nerve regeneration
03

In context

Cubital Tunnel Syndrome

35 studies on the registry are indexed under Cubital Tunnel Syndrome; 6 are open to participants now.

This study's planned enrollment of 30 is below the median of 65 across 25 interventional studies indexed under Cubital Tunnel Syndrome.

Browse Cubital Tunnel Syndrome studies →

Lead sponsor

University of Alberta is the lead sponsor of 823 studies on the registry; 169 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients aged >18 yr,
  2. If signs and symptoms of severe CuTS (ie, McGowan-Goldberg grade 3) were observed,
  3. If needle EMG examination showed evidence of chronic motor axonal loss and reduced recruitment in the ulnar-innervated intrinsic hand muscles, and
  4. If electrophysiologic evidence of severe motor axonal loss with motor unit number estimation (MUNE) greater than 2 standard deviations below the normative mean.

Exclusion criteria

Exclusion Criteria:

1) Patients were excluded if they had concurrent nerve injury, prior surgery for CuTS or coexisting neurologic conditions

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Control

    Control patients will receive cubital tunnel surgery and sham stimulation.

    Procedure: Electrical stimulation

  • Experimental
    Conditioning electrical stimulation

    Patients in the stimulation group will receive surgery as well as 1 hour of 20 Hz electrical stimulation 7 days prior to surgery

    Procedure: Electrical stimulation

Interventions

  • ProcedureElectrical stimulation

    Patients with cubital tunnel syndrome will receive either surgery and sham stimulation, or conditioning electrical stimulation 7 days prior to surgery

06

What researchers measure

Primary outcomes

  1. Motor unit number estimation

    A quantitative physiological measure of the number of motor nerve fibres in the target muscle

    Time frame: 3 years

Secondary outcomes

  1. Key pinch strength

    A functional measure of the ulnar intrinsic hand muscles using a dynamometer

    Time frame: 3 years

  2. Disability of the Arm, Shoulder and Hand (DASH) Questionnaire

    A questionnaire to quantify the severity of motor and sensory symptoms

    Time frame: 3 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2022 (actual). Primary completion is estimated for Mar 2028, 71 months after the start.

Of 15 interventional studies with no phase under Cubital Tunnel Syndrome, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 48. This study's planned 71 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 18, 2022
First posted
May 27, 2022
StartActual
Apr 1, 2022
Primary completionEst.
Mar 31, 2028
CompletionEst.
Jun 28, 2028
Last update
Feb 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05395715
Responsible party
Sponsor
First posted
May 27, 2022
Start date
Apr 1, 2022
Primary completion
Mar 31, 2028 (estimated)
Completion
Jun 28, 2028 (estimated)
Last update
Feb 9, 2026

Study contacts

Ming Chan
Contact
Ming.Chan@ualberta.ca
(780) 492-1614

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion